Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Thomas Daikeler
Intravenous tocilizumab for the treatment of giant cell arteritis: a phase Ib dose-ranging pharmacokinetic bridging study - Arthritis Research & Therapy
Background Subcutaneous tocilizumab (TCZ SC) is approved globally for giant cell arteritis (GCA). This phase Ib study investigated the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of intravenous (IV) TCZ 6 and 7 mg/kg in patients with GCA.
Ninety-day outcome of patients with severe COVID-19 treated with tocilizumab - a single centre cohort study
Sava Mihaela, Sommer Gregor, Daikeler Thomas, Woischnig Anne-Kathrin, Martinez Aurélien E., Leuzinger Karoline, Hirsch Hans H., Erlanger Tobias E., Wiencierz Andrea, Bassetti Stefano, Tamm Michael, Tschudin-Sutter Sarah, Stoeckle Marcel, Pargger Hans, Siegemund Martin, Boss Renate, Zimmer Gert, Vu Diem-Lan, Kaiser Laurent, Dell-Kuster Salome, Weisser Maja, Battegay Manuel, Hostettler Katrin E., Khanna Nina a Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel...
Longitudinal versus cross-sectional IL-6 measurements in tocilizumab-treated GCA. Response to: ‘Analysis of IL-6 measurement in GCA patients treated with tocilizumab should consider concomitant treatment with prednisone’ by Samson and Bonnotte
Longitudinal versus cross-sectional IL-6 measurements in tocilizumab-treated GCA.
The target uric acid level in multimorbid patients with gout is difficult to achieve: data from a longitudinal Swiss single-centre cohort
Ankli Barbara, Berger Christoph T., Haeni Nicolas, Kyburz Diego, Hügle Thomas, So Alexander K.-L., Daikeler Thomas a Department of Rheumatology, University Hospital Basel, Switzerland b Department of Rheumatology, Schmerzklinik Basel, Switzerland c Medical Outpatient Clinic, University Hospital Basel, Switzerland d Department of Biomedicine, Translational Immunology Laboratory, University Hospital Basel, Switzerland e Faculty of Medicine, University of Basel, Switzerland f Service de...
Longitudinal versus cross-sectional IL-6 measurements in tocilizumab-treated GCA response to: ‘Analysis of IL-6 measurement in GCA patients treated with tocilizumab should consider concomitant treatment with prednisone’ by Samson et al
Longitudinal versus cross-sectional IL-6 measurements in tocilizumab-treated GCA response to: ‘Analysis of IL-6 measurement in GCA patients treated with tocilizumab should consider concomitant treatment with prednisone’ by Samson et al Free Christoph T Berger1,2, Thomas Daikeler3 1Translational Immunology, Department of Biomedicine, University Basel, Basel, Switzerland 2Clinical Immunology, University Hospital Basel, Basel, Switzerland 3Clinic for Rheumatology, University Hospital Basel,...
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Thomas
Contact Thomas, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack